TBPH: Theravance Biopharma, Inc. Stock

SIC 2834 – Pharmaceutical Preparations

Valuation
Market Cap ($M) 429.05
Enterprise Value ($M) 332.97
Book Value ($M) 193.69
Book Value / Share 3.96
Price / Book 2.22
NCAV ($M) -49.03
NCAV / Share -1.00
Price / NCAV -8.75

Profitability (mra)
Return on Invested Capital (ROIC) -0.19
Return on Assets (ROA) -0.11
Return on Equity (ROE) -0.19

Liquidity (mrq)
Quick Ratio 5.20
Current Ratio 5.20

Balance Sheet (mrq) ($M)
Current Assets 119.31
Assets 362.03
Liabilities 168.34
Debt n/a
Equity n/a

Income Statement (mra) ($M)
Revenue 0.00
Operating Income 0.00
Net Income 0.00
Earnings Per Share Basic And Diluted n/a

Cash Flow Statement (mra) ($M)
Cash From Operations 0.00
Cash from Investing 0.00
Cash from Financing 0.00

(click for more detail)

File Date Form Activist 13D/G Investors Ownership
(%)
Change
(%)
6 days ago 13G/A BlackRock, Inc. 7.60
09-09 13G/A Baupost Group Llc/ma 0.00 -100.00
08-16 13G Newtyn Management, LLC 8.40
06-11 13G/A Odre 2005 Slu 0.00 -100.00
05-03 13G/A Madison Avenue Partners, LP 17.50 21.38
03-05 13D/A Weiss Asset Management LP
02-14 13G Irenic Capital Management LP 5.50
02-13 13G/A Vanguard Group Inc 7.01 -37.23
02-08 13G/A BlackRock Inc. 9.20 -13.98

Top 13F Investors Shares
(1000)
Change
(%)
Value
($1000)
Change
(%)

(click for more detail)

Date Insider Trades Code Shares Value

(click for more detail)

File Date Form SEC Filings
2024-08-08 10-Q UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549 Form 10-Q
2024-05-15 10-Q UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549 Form 10-Q
2024-03-01 10-K UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549 FORM 10-K
2023-11-09 10-Q UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549 Form 10-Q

(click for more detail)
Short Volume
Market Date Short Volume Total Volume Short Volume Ratio
2024-10-29 11,882 168,732 7.04
2024-10-28 10,828 119,098 9.09
2024-10-25 7,136 50,438 14.15
2024-10-24 5,001 60,985 8.20

(click for more detail)

Similar Companies
STRO – Sutro Biopharma, Inc. SUPN – Supernus Pharmaceuticals, Inc.
TARA – Protara Therapeutics, Inc. TCRX – TScan Therapeutics, Inc.
TKNO – Alpha Teknova, Inc.


Financial data and stock pages provided by
Fintel.io